(株)免疫生物研究所
株価チャート
2026/10/09 19:27 更新株価トレンド
2026/10/09 19:27 更新株価・取引詳細
2026/10/09 19:27 更新株価
取引
株主構成
2026/10/01 更新配当履歴 1年連続増配
2026/10/04 更新| 年度 | 配当金 | 変化 |
|---|---|---|
| 2026 | ¥6 | +20.0% |
| 2013 | ¥5 | - |
財務パフォーマンス
2026/10/04 更新売上・利益
利益率
キャッシュフロー
財務健全性
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| 損益計算書 | ||||
| 売上高 | ¥8億 | ¥8億 | ¥10億 | ¥10億 |
| 売上総利益 | ¥5億 | ¥5億 | ¥6億 | ¥7億 |
| 営業利益 | ¥1億 | ¥1億 | ¥2億 | ¥3億 |
| 経常利益 | -¥3億 | ¥1億 | ¥2億 | ¥3億 |
| 当期純利益 | -¥3億 | ¥2億 | ¥2億 | ¥3億 |
| EPS | -¥31.10 | ¥20.05 | ¥26.74 | ¥35.33 |
| 営業利益率 | 7.19% | 12.77% | 21.59% | 27.99% |
| 貸借対照表 | ||||
| 総資産 | ¥14億 | ¥16億 | ¥18億 | ¥22億 |
| 純資産 | ¥11億 | ¥13億 | ¥15億 | ¥18億 |
| 総負債 | ¥4億 | ¥4億 | ¥3億 | ¥3億 |
| 現金 | ¥6億 | ¥7億 | ¥8億 | ¥10億 |
| 有利子負債 | ¥2億 | ¥2億 | ¥2億 | ¥2億 |
| 自己資本比率 | 75.20% | 78.17% | 82.06% | 85.53% |
| D/Eレシオ | 0.22 | 0.19 | 0.13 | 0.10 |
| キャッシュフロー | ||||
| 営業CF | ¥0億 | ¥1億 | ¥2億 | ¥3億 |
| 投資CF | ¥0億 | -¥0億 | -¥1億 | -¥1億 |
| 財務CF | ¥0億 | ¥0億 | -¥0億 | -¥0億 |
| フリーCF | ¥0億 | ¥1億 | ¥1億 | ¥3億 |
| 効率性 | ||||
| ROE | -26.86% | 14.75% | 16.45% | 17.85% |
| ROA | -20.20% | 11.53% | 13.50% | 15.27% |
最新IR情報
-
製造拠点集約に関するお知らせ
TGカイコサービスの製造拠点の一つ三笠研究所を2027年5月で閉鎖し、前橋研究所...
詳細を読む -
お知らせ:検査サービスの終了に関するお知らせ
検査サービス「LipoSEARCH」「LipoTEST」「LipoCULTURE...
詳細を読む -
(開示事項の経過)抗 HIV 抗体の GLP 準拠反復投与毒性試験に関するお知らせ
共同保有特許に関連する抗HIV抗体のGLP準拠反復投与毒性試験の動物試験パートが...
詳細を読む -
抗HIV抗体開発の状況及びスケジュールに関するお知らせ
AMED支援下で抗HIV抗体の非臨床毒性試験が順調。治験薬製造開始を46期中に計...
詳細を読む
最新ニュース (5件)
企業情報
会社概要
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.